CN Patent

CN103656616B — 巴替非班注射剂及其制备

Assigned to Baotai Biological Pharmaceutical Co Ltd · Expires 2016-03-30 · 10y expired

What this patent protects

本发明涉及巴替非班及其药学上可接受盐的注射剂，及其制备和药学应用。结果显示，该注射剂在生产和临床使用中具有良好的稳定性和安全性。

USPTO Abstract

本发明涉及巴替非班及其药学上可接受盐的注射剂，及其制备和药学应用。结果显示，该注射剂在生产和临床使用中具有良好的稳定性和安全性。

Drugs covered by this patent

Patent Metadata

Patent number
CN103656616B
Jurisdiction
CN
Classification
—
Expires
2016-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Baotai Biological Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.